Previous Article | Next Article ![]()
Applied and Environmental Microbiology, March 2002, p. 1297-1304, Vol. 68, No. 3
0099-2240/02/$04.00+0 DOI: 10.1128/AEM.68.3.1297-1304.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
A. Pereira, and N. Simões*
Centro de Investigação de Recursos Naturais and Departamento de Biologia, Universidade dos Açores, 9501-801 Ponta Delgada, Açores, Portugal
Received 1 August 2001/ Accepted 20 December 2001
|
|
|---|
|
|
|---|
X. nematophila is carried by the infective juvenile nematode in a diverticulum of the gut, from an insect cadaver to a new host (1). The infective juvenile releases the bacterium in the insect hemocoel within 5 h of invasion. This complex causes an acute disease, which kills insects within 48 h (2). The injection of a few X. nematophila organisms in a susceptible insect larva causes growth inhibition and the death of the insect. During the pathogenic phase, X. nematophila is able to survive the vigorous attack of the insect immune system, proliferate in the hemolymph, and kill the larva. Because the number of organisms in the insect hemolymph is very low before insect death, Forst and Nealson (20) hypothesized that X. nematophila entered in an intraphagosomal phase and that during this phase the bacteria secrete some factors toxic to the insect. Since the bacterial proliferation does not occur in the hemocoel before insect death it is suggested that the secretions of these pathogens are highly potent virulence factors in insects. Furthermore, X. nematophila appears to be generally resistant to the attack of nonspecific antibacterial enzymes of insect hemolymph (13). Also, lipopolysaccharides of X. nematophila have been shown to prevent the process of the activation of prophenoloxidase into phenoloxidase (12, 14). The set of mechanisms by which the X. nematophila bacteria are able to circumvent the host defense systems and cause insect death, as well as the benefits provided by the bacteria to their symbiotic nematodes, is frequently associated with the extracellular molecules produced by Xenorhabdus spp. (4, 14, 21). Photorhabdus luminescens, a bacterium associated with the entomopathogenic nematode Heterorhabditis bacteriophora, also has a high secretory activity. The virulence of the strain W14 is partially clarified by the characterization of high-molecular-weight toxin complexes. These proteins are secreted and present an oral toxicity to the Lepidoptera (7). However, differences in the genomic organization have been reported when the toxic loci found in P. luminescens are compared to their homologues in X. nematophila (18). Recently, two overlapping cosmid clones were shown to encode an insecticidal protein DNA region of a highly pathogenic isolate of X. nematophila in Escherichia coli (35).
Among the extracellular molecules produced by X. nematophila, we can find some with proteolytic activities. Although those molecules may play a role in insect toxicity, their importance is highly conflicting. Certain literature acknowledges that proteases might have a role in insect toxicity by analogy with proteases produced by other insect pathogens (23, 39), whereas other authors claim that these proteases are not toxic to the insects, neither by injection nor by oral feeding (6). In this work, we report the identification of two proteases produced by X. nematophila and the characterization of one of these. In addition, we show that this protease suppresses antibacterial peptides involved in the insect immune response, thereby providing a role for it in the pathogenic process.
|
|
|---|
Protease II purification.
All experiments were performed at room temperature unless otherwise stated. The isolation protocol entailed starting with 800 ml of broth which was then concentrated to 15 ml through an Amicon ultrafiltration system (molecular mass cutoff, 50 kDa). The retentate was filtered with Swinnex (membrane pore size, 0.45 µm) and then loaded at 1 ml/min onto a DEAE-Sepharose column (2.5 by 20 cm) equilibrated with 10 mM cacodylate buffer, pH 7.6 (buffer A), connected to a Pharmacia fast-performance liquid chromatography system. Bound proteins were eluted in a linear gradient of 0 to 1 M of NaCl in buffer A over 60 min, and 1-ml fractions were collected. The proteolytically active fractions from this initial separation were subsequently pooled, desalted by gel filtration PD10 (Pharmacia Biotech, Uppsala, Sweden) in buffer A, and loaded (1 ml/min) onto a 5-ml HiTrap Q Sepharose column (Pharmacia Biotech), equilibrated with buffer A. The bound proteins were eluted in a step (0.1 M) gradient from 0 to 0.5 M NaCl in buffer A. The active fractions from HiTrap Q Sepharose were further separated using a Mono Q column (Pharmacia Biotech) and a linear gradient of 0.35 to 0.45 M of NaCl in buffer A over 120 min at 1 ml/min. Protein elution was monitored at 280 nm.
Enzyme activities.
The crude extract and chromatographic samples were assayed for proteolytic activity using azocasein (Sigma, St. Louis, Mo.) as a substrate (42). Aliquots (50 µl) of samples were added to 50 µl of 2% azocasein in Tris-HCl, pH 8, containing 0.2 M NaCl. Fractions were then incubated at 37°C for 1 h. Nondigested azocasein was precipitated by adding 130 µl of 10% trichloroacetic acid (TCA) (Merck, Darmstadt, Germany) to the incubations and centrifuged at 10,000 x g for 10 min. The supernatants (100 µl) were transferred to a 96-well microtitration plate containing 200 µl of 1 M NaOH. The absorbance values of the resulting supernatants were measured with a microplate reader (Bio-Rad Laboratories, Richmond, Calif.) with a 440-nm absorbance filter. Increased absorbance indicates the presence of proteolytic activity. The blank was obtained by precipitating the substrate plus the sample in TCA without incubation.
SDS-PAGE and immunoblot analysis.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed with a Mini-PROTEAN II gel system (Bio-Rad Laboratories), using slab gels, 0.5 mm thick, of 10% polyacrylamide, according to the method of Laemmli (32), and the proteins were stained with Coomassie blue G-250. Silver nitrate staining was performed according to the method of Morrissey (36). A prestained SDS-PAGE protein kit containing phosphorylase b (106.0 kDa), bovine serum albumin (77. 0 kDa), ovalbumin (50.8 kDa), carbonic anhydrase (35.6 kDa), soybean trypsin inhibitor (28.1 kDa), and lysozyme (20.9 kDa) (Bio-Rad Laboratories, Hercules, Calif.) was used as a source of molecular mass standards.
For the Western blotting, the purified protein was separated in gel electrophoresis under reduction and denaturing conditions. A Laemmli buffer, containing 5% ß-mercaptoethanol and heated at 95°C during 5 min, was used to achieve these conditions. The protein was then transferred onto a nitrocellulose membrane (Millipore Corp., Bedford, Mass.) using a liquid transfer apparatus in a continuous buffer system at pH 11, containing Tris-glycine and 20% methanol, applying 0.8 mA/cm2 for 1 h according to the method of Towbin et al. (43). The membrane was then incubated in Tris-buffered saline (TBS) (0.01 M Tris-HCl, pH 7.5, 0.1 M NaCl) containing 5% (wt/vol) dehydrated milk and 0.05% (vol/vol) Tween 20 for 30 min at room temperature. Subsequently, the membrane was incubated with primary antibody at the appropriate concentration (1:1,000 dilution) in TBS containing 5% (wt/vol) dehydrated milk and 0.05% (vol/vol) Tween 20 for 2 h at room temperature. The membrane was washed three times for 10 min in TBS containing 0.05% (vol/vol) Tween 20, followed by incubation with goat anti-rabbit immunoglobulin G peroxidase conjugates (Sigma) diluted 1:4,000 in TBS. Immunoreactivity was detected by incubating the membrane in TBS containing 0.06% (wt/vol) diaminobenzidine, 0.018% NiCl2 (wt/vol), and 0.3% H2O2 (vol/vol).
Zymography.
SDS-PAGE zymograms were performed as described by Schmidt et al. (39) with minor modifications. Ten percent polyacrylamide gels were copolymerized with 0.05% gelatin. Samples were dissolved in nonreducing Laemmli sample buffer without heat denaturation and run at 100 V. Following electrophoresis, the gels were washed for 30 min in 50 mM Tris-HCl buffer, pH 7.6, containing 2.5% Triton X-100 (Merck), with gentle agitation, in order to remove the excess of SDS. Then, the gels were incubated for an additional 4 h with several changes in a solution of 50 mM Tris-HCl, pH 7.6, containing 0.2 M NaCl and 5 mM CaCl2. Zones of proteolysis were detected by overnight Coomassie blue staining.
2D electrophoretic analysis.
A 1-ml fraction from the Mono Q purification step was precipitated with TCA, to a 10% final concentration, and centrifuged for 10 min at 10,000 x g. The pellet was dried and resuspended with rehydration buffer {9.8 M urea, 0.5% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate [CHAPS], 10 mM dithiothreitol, 0.5% ampholytes [pH 3 to 10], 0.001% bromophenol blue}. The sample was loaded into 7-cm-long ready strips (Bio-Rad Laboratories), previously rehydrated, with the buffer mentioned above, for 12 h at 20°C, according to the manufacturer's recommendations. Strips were focused in 3 steps: step 1, 250 V for 15 min; step 2, 250 to 4,000 V for 2 h; step 4,000 V for 5 h. Prior to running the second dimension (2D) SDS-PAGE, the strips were equilibrated in a solution of 6 M urea, 2% SDS, 0.375 M Tris-HCl (pH 8.8), 20% glycerol, and 0.130 M dithiothreitol and in a solution of 6 M urea, 2% SDS, 0.375 M Tris-HCl (pH 8.8), 20% glycerol, and 0.135 M iodoacetamide, which were used separately for 15 min to overlay the strip. Following this SDS-PAGE was performed in a 1.5-mm-thick 10% acrylamide gel under the conditions already described.
Protein determination.
The soluble protein concentrations were determined at all purification steps by the Coomassie blue dye binding method (8). Bovine serum albumin (1 mg/ml) was used as a standard protein.
Analysis of substrate susceptibility to protease II.
Several chromogenic substratesN-acetyl-Ile-Glu-Ala-Arg-paranitroanilide (pNA), N-benzoyl-Pro-Phe-Arg-pNA hydrochloride, N
-benzoyl-L-arginine-pNA hydrochloride, N-benzoyl-Phe-Val-Arg-pNA hydrochloride, N-carbobenzyloxy (CBZ)-Gly-Gly-Leu-pNA, D-Ile-Phe-Lys-pNA, N-succinyl-Gly-Gly-Phe-pNA, N-tosyl-Gly-Pro-Arg-pNA, DL-Val-Leu-Arg-pNA, and N-succinyl-Ala-Ala-Pro-Phe-pNA (Sigma)were prepared at a 10 mM stock solution in methanol.
Reactions began with the addition of 1.76 µg of protease II (80 µl from Mono Q fraction) to 20 µl of 10 mM substrate and 100 µl of Tris-HCl, pH 8. The change in optical density at 410 nm was determined every 5 min for 30 min using a Bio-Rad microplate reader. Negative controls consisted of heat-inactivated protease II mixed with substrate.
Kinetic analysis.
Kinetic assays were performed at room temperature using DL-Val-Leu-Arg-pNA and N-tosyl-Gly-Pro-Arg-pNA as substrates. The reaction mixture contained 1.76 µg of protease II (80 µl), and substrate concentrations ranged from 0.0001 M to 0.0024 M. Optical density was measured every 5 min over a 60-min interval with a Bio-Rad microplate reader at 410 nm. Vmax and Km values were determined by using the Lineweaver-Burk presentation. Reactions were run in triplicate.
Determination of optimal pH for protease II activity.
The reactions between purified protease II and substrate DL-Val-Leu-Arg-pNA were assayed in triplicate for 30 min in solutions ranging from pH 2 to 11. Controls consisted of substrate at the pH values tested without protease II. The conditions of the assay were those used for substrate susceptibility except for the buffer applied.
Inhibition and heat stability.
The chromatographically purified protease II was assayed against azocasein in the presence of protease inhibitors: antipain, chymostatin, leupeptin, phosphoramidon, aprotinin, E-64, pepstatin, bestatin, EDTA, and Pefabloc (Boehringer, Mannheim, Germany). Azocasein hydrolysis was measured as described above after a 30-min incubation of protease II with the inhibitor, at room temperature.
The optimal temperature was determined by protease II and azocasein incubated at different temperatures (4, 10, 23, 37, 45, 55, and 65°C) for 1 h, and this was followed by the determination of the proteolytic activity. The heat stability was determined by incubation of protease II at 55, 60, and 65°C for 10 min, and the remaining proteolytic activity measured has been described above.
Assays for antibacterial activity inhibition.
A slightly modified growth inhibition zone assay described by Hoffmann et al. (25) was used. Hemolymph with antibacterial activity was collected from Galleria mellonella and Pseudaletia unipuncta (Lepidoptera: Noctuidae) 24 h postinoculation with E. coli. Twenty microliters of active hemolymph was incubated with 0.44 µg of protease II in 60 µl of 0.1 M phosphate buffer, pH 6.4, at 37°C for 1 h. Treated and untreated hemolymph was tested for antibacterial activity by placing 30 µl of each in wells prepared on E. coli pour plates (105 organisms per plate). Plates were then incubated overnight at 37°C. Diameters of the growth inhibition zones were recorded. Assays with 1% cecropin A (Sigma) were performed under the same protocol.
A bacteriolytic assay was performed, with slight modifications, according to the method of Kaaya (29). Log-phase E. coli was centrifuged and suspended in ice-cold 0.1 M phosphate buffer, pH 6.4, to give it a density of 0.3 to 0.5 at 595 nm. A volume of 45 µl of 1% cecropin A, incubated for 1 h at 37°C with protease II or with heat-inactivated protease II (control), was added to 200 µl of bacterial suspension. The mixture was then incubated for 30 min at 37°C. After the incubation, the absorbance at 595 nm was measured with a Bio-Rad microplate reader within 1 h.
Susceptibility of hemolymph proteins to protease II.
Hemolymph from G. mellonella and P. unipuncta was collected under ice-cold conditions, in Eppendorf tubes with a few crystals of phenylthiourea (Sigma). The hemolymph was centrifuged for 10 min at 4°C and 10,000 x g. The supernatant corresponding to the serum was recovered, and aliquots of various volumes were incubated with 1.90 µg of active and heat-inactivated protease. A final volume of 200 µl was obtained by adding 0.01 M Tris-HCl, pH 8. The mixtures were incubated at 37°C for 1 h and then subjected to SDS-PAGE analysis under the conditions described above.
Preparation for the N-terminal amino acid sequence and internal sequences.
Chromatographic pure fractions of protease II were subjected to SDS-PAGE and electroblotted onto polyvinylidene fluoride (PVDF) membrane (Millipore). Tris-glycine buffer, pH 11, containing 20% methanol was used as electrophoretic buffer in a Mini Trans-Blot Cell (Bio-Rad Laboratories). Protease II on PVDF membrane was stained with a solution of 0.5% Ponceau red (Fluka, Buchs, Switzerland), washed with water, excised, and subjected to analysis.
The N-terminal amino acid sequence analysis was performed by automated Edman degradation (17). Additional internal sequences were obtained after digestion with endo-Lys-C. Peptide fragments produced by the digestion were isolated by reverse-phase high-performance liquid chromatography and four were sequenced. The analysis of the peptide sequences was performed by the Emory University Microchemical Facility (Atlanta, Ga.).
Peptide sequences were compared with entries in various sequence databases using the European Bioinformatics Institute FASTA program. A BLOSUM62 matrix was used (38).
Peptide synthesis and production of peptide-specific antibodies.
The peptide Prot. II-29 was synthesized according to the amino acids sequence resulted from the digestion of the purified protease. The peptide synthesis was performed according to the manufacturer (Emory University Microchemical Facility). The synthesized peptide was then linked to a carrier protein, keyhole limpet hemocyanin, with the goal of increasing the immunogenicity of the peptide, and then injected intradermally into a rabbit (Eurogentec Laboratories, Seraing, Belgium). The antiserum was collected 6 weeks later.
|
|
|---|
![]() View larger version (38K): [in a new window] |
FIG. 1. Release of proteolytic activity during the growth of X. nematophila in TSB broth. Samples of culture medium supernatants were collected at different times to determine the release of proteolytic activity measured at 440 nm using azocasein as a substrate.
|
![]() View larger version (45K): [in a new window] |
FIG. 2. Zymography analysis of the X. nematophila proteases released during 24 h of growth. Samples from the X. nematophila culture medium supernatants were collected at different times, dissolved in nonreducing Laemmli sample buffer, and applied to a 10% polyacrylamide gel containing 0.05% gelatin. The incubation and staining of the postrun gel were carried out as described in Materials and Methods. Shown are samples at 6 (lane 1), 12 (lane 2), 18 (lane 3), and 24 (lane 4) h of growth.
|
![]() ![]() ![]() View larger version (56K): [in a new window] |
FIG. 3. Purification of protease II from concentrated culture supernatant of X. nematophila. (A) Separation of two protease fractions by anion-exchange chromatography. Elution consisted of a gradient with 10 mM cacodylate, pH 7.6, containing 0 to 1 M NaCl over 60 min. The protease activity of each fraction, as indicated by the absorbance at 440 nm, was determined under the conditions described in Materials and Methods. (B) Elution of protease II from the HiTrap Q column. The proteins were eluted in a step gradient with 10 mM cacodylate, pH 7.6, containing 0 to 0.5 M NaCl. (C) Elution profile of protease II from a Mono Q column. The proteins were eluted in a linear gradient with 10 mM cacodylate (pH 7.6) containing a 0.35 to 0.45 M concentration of NaCl over 120 min.
|
![]() View larger version (33K): [in a new window] |
FIG. 4. Zymography analysis of purified proteases separated by DEAE column chromatography. Lanes: 1, crude extract; 2, fraction from exclusion (protease I); 3, fraction from elution (protease II).
|
|
View this table: [in a new window] |
TABLE 1. Purification of X. nematophila protease II
|
![]() View larger version (31K): [in a new window] |
FIG. 5. Analysis of protease II by SDS-PAGE, Western blot, and 2D electrophoresis. (A) SDS-PAGE and Western blot analysis of purified protease II. Lane 1 contains the Mono Q fraction showing purified protease II. Protein (4.4 µg) was applied to a SDS-10% PAGE gel. The electrophoretic run was performed at 100 V, and the gel was subsequently silver stained. Lane 2 shows the results of Western blot analysis of 2 µg of purified fraction using antibodies raised against Prot.II-29 peptide as the primary antibody. (B) 2D analysis of purified protease II. A concentrated sample of protease II was applied to a 7-cm ready strip gel to perform the first-dimension step. The 2D step was performed in an SDS-10% polyacrylamide gel that was silver stained. IEF, isoelectric focusing.
|
|
View this table: [in a new window] |
TABLE 2. Substrate sensitivity to protease II
|
The inhibition profile of the purified enzyme was evaluated using several protease inhibitors. The protease II activity on azocasein was not affected by leupeptin, aprotinin, E-64, bestatin, phosphoramidon, or 1.3 mM EDTA (Table 3). The serine protease inhibitor Pefabloc SC significantly inhibited the proteolytic activity of protease II, since only 7% of the residual activity was measured in the presence of a 4 mM concentration of inhibitor. Chymostatin, a chymotrypsin inhibitor, inhibited the protease, but less effectively than Pefabloc, since only 55% of the activity was retained. A small inhibition was also detected in the presence of antipain, a serine protease inhibitor. These inhibitions by the serine protease inhibitors suggest that the protease II purified from the X. nematophila growth medium is a serine protease. EDTA causes inhibition when it is used at 20 mM.
|
View this table: [in a new window] |
TABLE 3. Inhibitor reactivity with protease II
|
![]() View larger version (26K): [in a new window] |
FIG. 6. Proteolytic activity of protease II at different pH values and at different temperatures. (A) The optimum pH was determined by using DL-Val-Leu-Arg-pNA as a substrate in the conditions described in the Materials and Methods. (B) The optimum temperature was determined against azocasein as previously reported. O.D., optical density.
|
|
View this table: [in a new window] |
TABLE 4. Identity determined by FASTA using a BLOSUM62 matrix
|
![]() View larger version (66K): [in a new window] |
FIG. 7. Analysis of protease II by Western blotting. X. nematophila growth media collected at different times and purified protease II were transferred to nitrocellulose membranes. Proteins were detected by Western blotting using antibodies raised against Prot.II-29 peptide as primary antibody. Lanes: 1, 18 h of growth in medium; 2, 24 h of growth in medium; 3, purified fraction.
|
Protease II was able to reduce as much as 100% of the antibacterial activity on the hemolymph of inoculated G. mellonella and P. unipuncta larvae, as well as destroy cecropin A activity on the growth inhibition zone assays. Ninety-seven percent of the cecropin A lytic capacity was also reduced by protease II in in vitro assays.
Protease II apparently had no activity on the proteins of the extracellular matrix, such as collagen, elastin, and fibrin (data not shown).
|
|
|---|
Protease II is a 60-kDa protein with a pI of 8.5. This enzyme probably belongs to the serine protease family. Pefabloc SC and chymostatin, two serine protease inhibitors, inhibited protease II, totally and partially, respectively. Two chromogenic substrates, N-tosyl-Gly-Pro-Arg-pNA and DL-Val-Leu-Arg-pNA, specific for serine proteases, are positively hydrolyzed by protease II, whereas the inhibition induced by EDTA, a metalloprotease inhibitor, at a significant concentration is negligible.
Protease II is expressed during just a few hours at the beginning of the exponential growth phase of X. nematophila. On the other hand, the closely related entomopathogenic bacterium, P. luminescens, releases proteases in the stationary growth phase. These proteases have little or no toxic activity in insects, neither by injection nor by oral feeding, but the participation of these molecules on the activation of a toxic complex of proteins secreted by P. luminescens was not excluded (6).
Protease II clearly destroyed the antibacterial activity on the hemolymph from immune G. mellonella and P. unipuncta larvae. Moreover, protease II inhibited cecropin A, an inducible antibacterial peptide that is particularly active against gram-negative bacteria, isolated from several species of Lepidoptera and Diptera (19, 24). In the same way, two hemolymph serine protease inhibitors involved in P. unipuncta humoral defense showed no effect on proteolytic activity released by X. nematophila (9). The inactivation of antibacterial factors in insects must cause an immunodepression that enhances the ability of X. nematophila to establish itself in the hemocoel, causing a septicemia followed by insect death. In addition to showing the destruction of antibacterial factors, we showed that protease II is able to promote the digestion of some proteins of the insect hemolymph. The hydrolysis of these proteins may provide nutritional factors to the associated nematode necessary for its complete development. Axenic S. carpocapsae is able to invade and kill G. mellonella larvae; however, the progeny of these nematodes, in the absence of the bacteria, is much reduced in relation to nematodes developing in monoaxenic conditions (5, 24). The optimal temperature and pH of protease II were 23°C and 7, which correspond to the optimal conditions for nematode development, either in insects or in in vitro culture (15).
The characterization of this protease indicated a strong relationship to other enzymes isolated from other bacteria, in such areas as molecular weight, substrate specificity, and the internal sequences that presented a high level of homology. Four peptides resulting from protease II internal digestion were sequenced. Amino acid sequences were computed for homologies with other toxic proteases excreted by bacteria. Fragments Prot II-29 and Prot II-45 are 75 and 68% identical to an alkaline metalloproteinase isolated from P. aeruginosa (16, 22). P. aeruginosa is commonly isolated from insects and is occasionally pathogenic under laboratory conditions (27). The pathogenicity of P. aeruginosa was correlated with the release of proteases that are involved in insect hemolymph clotting (30). The alkaline proteases of P. aeruginosa destroy the ground substance of supporting structures once they interfere with fibrin formation (33).
The analysis of the fragment Prot II-29 showed it to be 79% identical to a metalloprotease of Erwinia amylovora and 75% identical to the protease C precursor of Erwinia chrysanthemi. Bacteria of the genus Erwinia were reported in association with insects, even though they are not known to be pathogenic agents (3, 44).
Research is being conducted to show to what extent the role of protease II may be relevant to pathogenicity and how it may participate in nematode development inside insect hemolymph.
This work was supported by PRAXIS PCNA/C/BIA/190/96, from the Fundação para a Ciência e Tecnologia from Ministério Da Ciência e Tecnologia of Portugal. The first author was the recipient of a fellowship from the Luso-American Foundation for Development (FLAD).
Present address: Faculté des Sciences, Laboratoire de Biologie des Entomophages, Université de Picardie Jules Verne, Amiens 80039, France. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»